Work

A first-in-human phase I trial with antibody drug conjugate ADCT-701 in neuroendocrine tumors and carcinomas.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.4_suppl.tps672

Authors: Jaydira Del Rivero, John Glod, Tamika Magee, Kimberley Cooper, Anna Rivero, Tea Lanfranconi, Rashmika Patel, W Douglas Figg, Yves Pommier, Brigitte C. Widemann, Nitin Roper

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4406869552

FWCI: 1.246

Cites:

Cited by: 2

Related to: 10